Similarly, YY1, combined with HLJ1, acted as a tumour suppressor in HCC,12 whereas YY1 could promote HCC tumorigenicity and inhibit apoptosis of HCC cells through NF‐κB activation.13 This evidence concerns the gene NFKB1 and hepatocellular carcinoma.